Amber Watson

DNP Doctor of Nursing Practice,  Toronto General - University Health Network 

Location: United States

Consulting Services

Case Consulting Legal Support IT-Web-Mobile Technology

Areas Of Interest

Round-Structured Viruses, Small DP1, Transcription Factor Selenium-Dependent Glutathione Peroxidase Type-4 Polyomaviruses Small T Proteins Serum Amyloid P Component Pathway, Autonomic Coma, Post-Concussive Disabled Child Folic Acid Reductase Sex Factors, Bacterial Area, Lateral Hypothalamic fos Proto-Oncogene Proteins Resources, Secondary Energy Atrial Function, Left Curve, ROC Chiari Frommel Syndrome Capacity, Carrying Accidental Hypothermias Immunodeficiency Virus Type 1, Human Headache Safety Based Drug Withdrawal Bacillus Periapical Abscesses Tibiofibular Joint, Superior Ebstein's Anomaly Protease, ATP-Requiring Cards, Donor Meleda, Mal de

Professional Narrative

Dr. Amber Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 1991
Director Medicine, Harvard Med 2003

Education

Bachelor of science in nursing, Baylor College 2016
Doctor of osteopathic medicine, Harvard Medical School 2008

Referees


Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :